October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, announced today that the U.S. Food and Drug Administration (FDA) has provided clearance of the company’s Investigational New Drug (IND) application to initiate clinical testing of TN-401. 

October 30, 2023 — Shockwave Medical, Inc., which develops technologies for the treatment of cardiovascular disease, has announced the planned United States introduction of the Shockwave C2+ Coronary Intravascular Lithotripsy (IVL) catheter, following approval by the U.S. Food and Drug Administration. The enhanced C2+ catheter made its U.S.

October 30, 2023 — Boston Scientific Corporation on Friday announced positive 12-month results from the pivotal AGENT IDE clinical trial of the 

October 30, 2023 — Abbott announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK) in people with chronic limb-threatening ischemia (CLTI). CLTI is a severe stage of peripheral artery disease (PAD) due to advanced arterial blockage in the lower extremities.

October 30, 2023 — -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research on aortic stenosis (AS) was presented by cardiologist Philippe Généreux, MD, Director of the Struct

October 26, 2023 —  Royal Philips, a global leader in health technology, announced the latest results demonstrating the safety of Philips instant w

October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive heart devices in treating mitral and tricuspid valve disease.

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care solutions, today announced results from three clinical studies supporting the use

October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued a joint statement in response to the new research on aortic valve replacement in low-risk patients announced this week at the Transcatheter Cardiovascular

October 26, 2023 — A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in United States’ patients with cardiogenic shock.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now